title: Aggressive central giant cell lesion of the maxilla: surgical management and the use of adjuvant interferon alfa-2a.
authors.affiliation: Department of Plastic Surgery; Georgetown University (Baker, Parikh) Department of Pediatrics; Duke University; Durham, N.C. (Rhodes) Division of Pediatric Hematology and Oncology; Georgetown University; Washington, D.C. (Abu-Ghosh, Shad).
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Baker
authors.forename: Pranay M
authors.initials: PM
authors.lastname: Parikh
authors.forename: Deanne N
authors.initials: DN
authors.lastname: Rhodes
authors.forename: Amal
authors.initials: A
authors.lastname: Abu-Ghosh
authors.forename: Aziza T
authors.initials: AT
authors.lastname: Shad
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D018212:Giant Cell Tumor of Bone / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008441:Maxillary Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D009361:Neoplasm Invasiveness; D011994:Recombinant Proteins; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins